Dr. Lawrence Platt: Championing Innovation in Maternal-Fetal Medicine with Nuvo™

Dr. Lawrence Platt is a renowned expert in obstetrics and gynecology, with a distinguished career spanning more than 50 years. He is recognized for his groundbreaking work in fetal assessment, maternal care, and medical imaging technologies. With an impressive track record of collaborating with startups and advancing innovative healthcare solutions, Dr. Platt has consistently pushed the boundaries of maternal-fetal medicine to improve patient outcomes.

Currently, Dr. Platt lends his expertise to Nuvo™, a trailblazing medical technology company revolutionizing prenatal care. Nuvo’s flagship product, INVU, has secured two FDA approvals offering leading-edge solutions for remote fetal monitoring. This innovation is transforming the way expectant mothers and healthcare providers approach prenatal assessments. By combining advanced technology with user-friendly design, INVU by Nuvo™ provides expectant mothers convenience and peace-of-mind, thereby enhancing  the quality of care, improving patient compliance, and making prenatal monitoring more accessible than ever before.

‍

Transforming Prenatal Care with Nuvo

Dr. Platt’s expertise in gynecology and obstetrics has often led him to collaborate with startups in maternal and fetal health, and his journey with Nuvo™ began during its early stages. He was drawn to Nuvo’s potential to improve the quality of care for pregnancies through innovative, patient-centered solutions.

Nuvo’s solution addresses significant challenges in fetal assessment by offering the option to have certain monitoring sessions done in the comfort and convenience  of the expectant mother’s home or office. . This reduces the logistical burden on expectant mothers, minimizing the need for frequent travel and easing time commitments. For mothers facing challenges such as distance, childcare, or transportation issues, Nuvo’s technology provides a vital lifeline. Additionally, it alleviates the strain on healthcare providers by reducing in-office resource demands, leading to cost savings for both patients and medical facilities.

Remote care advancements, particularly those accelerated during the COVID-19 pandemic, have underscored the value of innovations such as INVU by Nuvo™. Nuvo’s solution delivers results that are equivalent or superior to traditional in-clinic  monitoring methods. This breakthrough has the potential to establish new standards in prenatal care, enhancing compliance and enabling earlier detection of fetal distress. The system is especially beneficial for high-risk pregnancies, as it allows continuous monitoring from virtually anywhere with internet access and a direct link to your physician, supporting better perinatal outcomes.

With its ability to save time, reduce costs, and improve outcomes for mothers and babies alike, Nuvo has the potential to revolutionize prenatal care, offering a brighter and safer future for families worldwide.

‍